Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma
Roniel Cabrera, David R. Nelson(Harvard University Press), Miguel Ararat(University of Florida), Clive Wasserfall(University of Florida), Chen Liu(Kunming University of Science and Technology), Yiling Xu(University of Florida), Todd M. Brusko(University of Florida), Lung Ji Chang(University of Florida), Mark A. Atkinson(University of Florida)
Cited by 108
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
|Genome Research|2011|2k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k